Analyst Ratings for Jazz Pharmaceuticals (JAZZ)

JAZZ Rating Summary

JAZZ Price Target Summary

* Over Last 12-Mos
  |   Expand Research on JAZZ
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $197.94 (+10.4%) * Over Last 12-Mos
Rating Score: 8.9 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/7/2021 RBC Capital
» Updated 5/5/2021
Daniel Busb New Coverage Outperform
(N/A)
190.00
(186.00)
164.71
(179.31)
8.86% Details
2/3/2021 Piper Sandler
» Updated 4/27/2021
David Amsellem Upgrade Overweight
(Neutral)
214.00
(205.00)
157.29
(179.31)
14% Details
Like JAZZ Ratings? Also take a look at GWPH, PHM, OYST, HRB

JAZZ Ratings News